4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-20-006427
SVP, Chief Technical Officer sold 21,387 shares at $23.80 ($509,075)
- SVP, Chief Technical Officer acquired 21,387 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LaBarre Michael J. · SVP, Chief Technical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-20 | Exercise or conversion : show line 1 in the form | +21,387 | $7.14 | $152,703 | 197,574 | D |
| 2020-05-20 | Sale : show line 2 in the form | −21,387 | $23.80 | $509,075 | 176,187 | D |
| Open-market sales · 21,387 sh · avg $23.80 · $509,075 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-05-20 | Exercise or conversion : show line 3 in the form Option to Purchase Common Stock | −21,387 | $7.14 | 2021-02-03 | 21,387 | 18,613 | D |
Loading xslF345X03/edgar.xml…